Article
Incorporating Next-Generation Sequencing as a Second-Tier Test for Primary Carnitine Deficiency.
Molecular genetics & genomic medicine - 1 Sept 2024
Lin Yiming, Zheng Zhenzhu, Lin Weihua, Peng Weilin
Abstract excerpt
BACKGROUND: Newborn screening (NBS) for primary carnitine deficiency (PCD) has poor performance. This study aimed to evaluate the feasibility of incorporating next-generation sequencing (NGS) as a second-tier PCD test. METHODS: Between March and December 2020, 60,070 newborns were screened for inherited metabolic disorders. Newborns with free carnitine (C0) levels below 8.5 μmol/L were selected for second-tier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
